Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Mazdutide vs Placebo and Dulaglutide in Chinese Patients with Type 2 Diabetes
NCT04965506Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Sep 2021
- Primary completion
- Apr 2022
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of mazdutide in type 2 diabetes mellitus (T2DM), sponsored by Innovent Biologics. Started Sep 2021; status: completed.
02
Drugs
mazdutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04965506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04965506.